Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer 177Lu-PSMA-617 therapy

Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer 177Lu-PSMA-617 therapy

BackgroundMany patients use artificial intelligence (AI) chatbots as a rapid source of health information. This raises important questions about the reliability and effectiveness of AI chatbots in delivering accurate and understandable information.PurposeTo evaluate and compare the accuracy, concise...

Full description

Bibliographic Details
Main Authors: Gokce Belge Bilgin, Cem Bilgin, Daniel S. Childs, Jacob J. Orme, Brian J. Burkett, Ann T. Packard, Derek R. Johnson, Matthew P. Thorpe, Irbaz Bin Riaz, Thorvardur R. Halfdanarson, Geoffrey B. Johnson, Oliver Sartor, Ayse Tuba Kendi
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-07-01
Series:Frontiers in Oncology
Subjects:
prostate cancer
177 Lu-PSMA-617 therapy
ChatGPT
Bard
artificial intelligence
machine learning
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1386718/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1386718/full

Similar Items